dorsaVi Acquires Groundbreaking Neuromorphic IP to Power Next Generation Robotics and Edge Intelligence.

dorsaVi Limited (ASX: DVL) has secured an exclusive neuromorphic and Processing-in-Memory (PIM) technology portfolio from Technion, led by global expert Prof. Shahar Kvatinsky. This transformational acquisition positions dorsaVi at the forefront of intelligent wearables, robotics, and adaptive biosensing systems. The PIM architecture merges computation and memory, enabling hardware that mimics the human brain’s reflexes and learning capabilities while dramatically reducing latency and power consumption. Integrated with dorsaVi’s FDA-cleared biosensor platform, this innovation transforms sensors into autonomous nodes capable of sensing, learning, and acting locally—eliminating reliance on cloud processing.

The dual-layer design, combining a “Reflex Engine” and “Adaptive Interface,” supports real-time calibration, noise-resilient signal capture, and adaptive control. With the global neuromorphic computing market expected to surpass US$20 billion by 2030, this strategic move shifts dorsaVi from reactive analytics to self-adapting edge systems, paving the way for smarter prosthetics, exosuits, and industrial safety technologies.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com